AIP
Ameritas Investment Partners Portfolio holdings
AUM
$3.27B
1-Year Est. Return
22.51%
1 Year Est. Return
+22.51%
AUM
$3.17B
AUM Growth
+$261M
(+9%)
Holding
3,406
Top Buys
| 1 | +$8.54M | |
| 2 | +$4.59M | |
| 3 | +$4.08M | |
| 4 |
Okta
OKTA
|
+$3.24M |
| 5 |
APi Group
APG
|
+$2.41M |
Top Sells
| 1 | +$5.39M | |
| 2 | +$4.09M | |
| 3 | +$3.05M | |
| 4 |
BERY
Berry Global Group, Inc.
BERY
|
+$2.11M |
| 5 |
X
US Steel
X
|
+$1.87M |
Sector Composition
| 1 | Technology | 23.69% |
| 2 | Industrials | 9.88% |
| 3 | Financials | 9.71% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Healthcare | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Orchestra BioMed
OBIO
$238M
| – | – |
-1,396
|
|
||
3377
Ocugen
OCGN
$528M
| – | – |
-25,068
|
|
||
3378
Organon & Co
OGN
$2.28B
| – | – |
-1,000
|
|
||
|
ONL
3379
Orion Office REIT
ONL
$121M
| – | – |
-5,639
|
|
||
3380
Offerpad Solutions
OPAD
$64.2M
| – | – |
-1,023
|
|
||
3381
Opendoor
OPEN
$6.36B
| – | – |
-64,866
|
|
||
3382
Outlook Therapeutics
OTLK
$35M
| – | – |
-607
|
|
||
3383
Ovid Therapeutics
OVID
$112M
| – | – |
-4,924
|
|
||
3384
PepGen
PEPG
$357M
| – | – |
-1,175
|
|
||
3385
Pliant Therapeutics
PLRX
$79.3M
| – | – |
-5,614
|
|
||
3386
Prelude Therapeutics
PRLD
$114M
| – | – |
-819
|
|
||
3387
ProKidney
PROK
$324M
| – | – |
-10,523
|
|
||
3388
Purple Innovation
PRPL
$83.4M
| – | – |
-4,415
|
|
||
3389
Pyxis Oncology
PYXS
$110M
| – | – |
-4,784
|
|